Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × cixutumumab × Clear all

NCT00639509 2014-05-23

IMC-A12 in Treating Patients With Advanced Liver Cancer

Phase 2 Completed

24 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular